$GSCG Yes indeed "Future of Medicine" Big pharma wants in.
Regenerative medicine has potential to displace current treatments in cardiovascular and metabolic disorders space, says GlobalData
New approvals expected to drive CVMD market growth
Regenerative medicine is under the spotlight for its potential to repair or replace damaged or diseased human cells or tissues to restore normal function.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.